Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00IXN
|
|||
| Former ID |
DIB008861
|
|||
| Drug Name |
GS-6637
|
|||
| Indication | Substance use disorder [ICD-11: 6C4Z] | Phase 1 | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C6H11BO2
|
|||
| Canonical SMILES |
B(C1=CCCCC1)(O)O
|
|||
| InChI |
1S/C6H11BO2/c8-7(9)6-4-2-1-3-5-6/h4,8-9H,1-3,5H2
|
|||
| InChIKey |
XZWQKJXJNKYMAP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 89490-05-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040688) | |||
| REF 2 | Clinical pipeline report, company report or official report of Gilead. | |||
| REF 3 | Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.